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ABSTRACT 
ROLE OF AUTOPHAGY IN THE RESPONSE OF HS578T BREAST TUMOR CELLS 
TO RADIATION 
 
By Shweta Moreshwar Chakradeo 
 
A dissertation submitted in partial fulfillment of the requirements for the degree of 
Master of Science at Virginia Commonwealth University 
 
Virginia Commonwealth University, 2012 
 
Major Director: David Gewirtz, PhD 
Professor, Department of Pharmacology and Toxicology 
 
Breast cancer is the most commonly observed cancer type in women and is the second 
leading cause of cancer death in women. Radiation can be used to debulk tumors prior to 
surgery as well as to treat patients after surgery and/or chemotherapy. Previous studies 
from our laboratory have shown that the anti –malarial drug chloroquine sensitizes breast 
cancer cell lines to radiation by suppression of autophagy which is a conservative 
catabolic process that can be cytoprotective. The scientific literature has demonstrated 
 xi 
that many tumor cell systems undergo cytoprotective autophagy and that pharmacological 
or genetic inhibition of autophagy leads to other modes of cell death such as apoptosis. 
Acridine orange staining was used for determination of acidic vacuole formation, an 
indication of autophagy and DAPI/TUNEL staining was used to identify apoptotic cells. 
Our studies in Hs578t breast tumor cells show the lack of sensitization by chloroquine 
upon autophagy inhibition with minimal apoptosis when cells are treated with 5 × 2Gy 
radiation. The extent of apoptosis was not increased upon autophagy inhibition by 
Chloroquine as determined by DAPI/TUNEL assays and quantified by Flow Cytometry 
using AnnexinV/PI. The potential role of senescence in the effects of radiation in the 
Hs578t cells was determined with the use of β-Galactosidase dye staining for senescence. 
It appears from these studies that autophagy need not to be cytoprotective in all breast 
cancer cell lines. Additional studies are in progress to effort to identify the factors that 
might distinguish between cytoprotective and non-cytoprotective autophagy. 
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SECTION 1: INTRODUCTION 
1.1 Cancer 
Cancer is a leading cause of death and accounts for about 13% of deaths worldwide 
(2008). (who.net). Treating cancer is very difficult due the existence of multiple 
mechanisms of resistance; in addition, tumors may metastasize to sites where radiation 
might not be practical and where drugs may have difficulty in gaining access. There are 
no prominent symptoms exhibited by many types of the cancers at their early stages, 
which makes them difficult to diagnose before the disease has metastasized.. The risk of 
developing cancer increases with age and about 77% of diagnosed cancers are in 
individuals 55 years and above.  (cancer.org) 
Cancer arises from abnormal growth of cells that have mutations in genes which control 
cell proliferation and survival. Both oncogenes and tumor suppressor genes can 
contribute to the development of cancer. Over expression of the oncogene, Her2/Neu, can 
cause cell transformation and plays an important role in tumorigenesis. The tumor 
suppressor gene p53 is essential in controlling abnormal cell proliferation and 
maintaining genomic integrity (Zhu & Bai, 2006, Vousden, 2002). Over half of the 
tumors examined show mutations in p53, a tumor suppressor gene (Tripathi et al 2004, 
Weinberg et al, 2000). 
Tumors can be malignant or benign. Benign tumors do not invade other tissues and are 
rarely life threatening (Choe et al, 2009). Benign tumors are localized (Choe et al, 2009) 
whereas malignant tumors invade into other tissues and furthermore frequently have the 
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capacity to metastasize and grow at distant sites (Holland-Frei Cancer Medicine. 5th 
edition). 
1.2 Cancer Statistics 
Excluding skin cancer, breast cancer is the most common malignancy among women, 
accounting for nearly 1 in 3 cancers diagnosed among women in the United States. 
(DeSantis, 2011). About 1 in 8 U.S. women will develop invasive breast cancer during 
her lifetime (U.S. Breast cancer statistics 2012). Breast cancer is the second leading cause 
of death in women in the United States. 
1.3 Breast Cancer 
Breast cancer is the leading cause of death in women in not only developed countries but 
also in developing countries (Porter, 2012). There are two forms of breast cancer which 
are commonly found, which are ductal and lobular. Ductal carcinoma is formed in the 
lining of a milk duct within the breast which carries milk from the breast to the nipple. 
Lobular carcinoma starts in the lobules of the breast where milk is formed (Mayo Clinic 
2012). Approximately 70-75% of breast cancers are estrogen receptor positive, and which 
are therefore likely to respond to hormone therapy (Wax, 2010). Approximately 12-17% 
of women with breast cancer have triple negative type cancer. Triple negative breast 
cancer cells do not express the estrogen receptor, progesterone receptor or the Her2 gene. 
Triple negative cancers are aggressive and have a very poor prognosis. Triple negative 
breast cancers cannot be treated with hormone therapy or targeted therapy (Her2 targeted 
therapy) (Reis and Filho, 2010). BT-549, Hs578t and HCC1806 are examples of triple 
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negative breast cancer cell lines (atcc.org). The studies presented in this thesis were 
performed in Hs578t cells which are also mutant in p53 (Choi et al, 2010). 
1.4 Current Treatments 
Breast cancer is generally treated with surgery, chemotherapy and radiation therapy often 
in combination with hormonal therapy. 
 Surgery:  Surgery is used as the primary treatment when cancer is localized. Surgeons 
can perform either a lumpectomy or mastectomy, depending on the progression of the 
disease. With a lumpectomy, only the tumor is removed with a small amount of 
surrounding tissues whereas with a mastectomy, removal of all the breast tissue is 
involved. Almost all patients with breast cancer have some therapeutic options for their 
surgery. (Dooley WC 1998). Surgery is the choice for treatment when the tumor is 
localized and has not metastasized although surgery is necessary to remove the primary 
tumor even when metastasis is likely to have occurred. 
Chemotherapy: In chemotherapy, anti-neoplastic agents are used to treat cancer. 
Chemotherapeutic drugs generally are most effective against rapidly dividing cancer 
cells. However, resistance development is one of the major limitations of chemotherapy. 
(Longley et al, .2008). Chemotherapy is utilized in order to weaken and destroy cancer 
cells at the original site as well as cancer cells that may have travelled to other parts of 
the body. Cytotoxic chemotherapy in both advanced and early stage breast cancer is well-
established. Depending on the molecular basis of cancer, chemotherapy can be 
personalized (Hussain SA 2010). Commonly used chemotherapy drugs in breast cancer 
are Taxol, Adriamycin, 5- Fluorouracil and Cyclophosphamide.  
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Hormonal Therapy: Estrogen is the principal hormone involved in the development of 
breast tumors. (Smith & Dowsett, 2003). Hormone therapy is widely used to treat 
estrogen receptor positive breast cancer. If breast cancers are estrogen receptor positive, 
they can be treated with hormonal therapy in two ways, either by lowering levels of 
estrogen in the body or by blocking actions of estrogen on breast cancer cells. (American 
Cancer Society 2012). Two types of drugs are widely used to treat breast tumors by 
hormone therapy. They are Tamoxifen and  Aromatase inhibitors.  Tamoxifen inhibits 
estrogenic effects by acting as a competitive antagonist for estrogen at the estrogen 
receptor site (Smith & Dowsett, 2003). Aromatase inhibitors decrease estrogen synthesis 
in the breast tumor by inhibiting the aromatase enzyme that is responsible for the 
conversion of androgen to small quantities of estrogen in post-menopausal women (Smith 
& Dowsett, 2003).  
Targeted Therapy: Targeted therapy is the most advanced approach to treat breast cancer. 
One of the agent which is widely used in such therapy is Trastuzumab which is the first 
approved targeted anti-cancer drug used in treating patients with HER-2 positive breast 
cancer. (Finn et al , 2012). Trastuzumab is a humanized monoclonal antibody which is 
capable of significantly improving recovery from metastatic breast cancer. Trastuzumab 
is generally given with conventional chemotherapeutic drugs such as Paclitaxel 
(Blackwell, 2008).  Another targeted therapy approach involves anti angiogenic 
compounds (Current Pharmaceutical Design, Vol 13 Issue 5) targeting growth factors 
which are important component of cancer growth as well as invasion and metastasis.  
Bevacizumab is a humanized monoclonal antibody against the pro-angiogenic factor, 
which is vascular endothelial growth factor (VEGF) (Kamby et al; 2010). Bevacizumab 
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was approved by FDA to use in breast cancer treatment but it is no longer used as it did 
not show any significant effect and possesses risk of some serious side effects (FDA, 
2011). 
Radiation Therapy:  Radiation therapy is a highly effective way to shrink tumors by 
killing cancer cells (American Cancer Society, 2012). Radiation therapy uses high power 
X-rays, particles or radioactive seeds to eliminate cancer cells. (ncbi.nlm.nih.gov). 
Ionizing radiation can cause loss of integrity of DNA and produces a wide variety of 
DNA damage (Masuda and Kamiya 2012). Patient can receive radiation externally by the 
use of a radiation beam or internally by delivering radiation sources inside the body 
(American Cancer Society, 2007).  
Like chemotherapy, radiation therapy is toxic not only to the tumor, but to surrounding 
healthy cells. To reduce this toxicity, patients receive smaller, fractionated doses of 
radiation; fractionated radiation also serves to increase the likelihood that cancer cells are 
exposed to radiation at the points in the cell cycle when they are most vulnerable to DNA 
damage. Patients who receive most types of external-beam radiation therapy may receive 
one dose (a single fraction), or multiple doses of radiation a day, up to 5 days a week for 
several weeks. Patients generally receive a total of between 40Gy to 60Gy in 2Gy doses. 
(American Cancer Society, 2010). 
Exposure to ionizing radiation (IR) induces single strand breaks (SSB), base damage and 
DNA- proteins cross links in the genomic DNA. (Balajee et al 2010). Among these, DNA 
double strand breaks (DSBs) are considered the most lethal form of DNA damage. They 
can be introduced by exogenous agents such as ionizing radiation (IR), topoisomerase 
poisons, radiomimetic drugs (e.g. bleomycin), and by cellular processes such as V (D) J 
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recombination. (Miller 2009, Povirk 2006, Helleday 2007). DNA damage caused by 
ionizing radiation can either be direct or indirect. Indirect damage is caused due to 
ionization of atoms which leads to formation of hydroxyl (OH) or O2 radicals (Hall & 
Giaccia, 2006). 
1.5 Apoptosis 
The term apoptosis was first introduced by Kerr, Wyllie and Currie in 1972. Apoptosis is 
a process of programmed cell death which is characterized by distinct morphological 
features such as membrane blebbing, cell shrinkage, chromatin condensation and DNA 
fragmentation at 3’-OH terminal (Potten et al, 2001). Apoptosis is a normal physiological 
process and it plays an important role in embryogenesis and ageing (Debatin et al, 2006). 
Apoptosis can be activated by DNA damage, stresses such as γ-radiation or cytotoxic 
chemotherapy (Debatin et al, 2006). 
The apoptosis process can follow one of the two main pathways, either Intrinsic or 
Extrinsic. Both pathways eventually lead to activation of caspases (Elmore, 2007). 
Caspases are the main components of the apoptosis process. So far, at least 14 caspases 
have been identified out of which 11 are found in humans cells (Shi, 2002). Caspases are 
generally divided into two types, initiators and effectors. Initiator caspases include 
Capases-2, -8, -9 whereas effector caspases include Caspase-3, -6, -7 (Shi et al, 2002). 
Initiator caspases are responsible for cleavage and activation of effector caspases. 
Effector caspases further break down different proteins which results in apoptosis 
(Kaufmann et al, 1999). Effector caspases such as Caspase-3, -6, -7 are capable of self-
activation (Kaufmann et al, 1999).  
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Extracellular death ligands such as FasL are responsible for activation of the extrinsic 
pathway. The death ligand FasL binds to death receptor such as Fas (Shi et al, 2002). 
Binding of death ligands to death receptors leads to formation of Ligand-Receptor 
complexes which further induces activation of cytosolic factors in action such as FADD 
and Caspase-8. Activation of Caspase-8 further activates Caspase-3 cleavage (Hengartner 
2000, Shi et al, 2002). 
The intrinsic Pathway is mediated by mitochondria. In the response to apoptotic stimuli, 
many proteins are released from the intermembrane space of mitochondria (Wang, 2001, 
Shi et al, 2002). BAX and BID are pro-apoptotic proteins which bind to the outer 
membrane of mitochondria and signal to release the inner content. Upon such release, 
cytochrome C forms a complex with ATP and Apaf 1 which in turn releases Caspase-9 
(Debatin et al, 2006). The complex of Cytochrome C, Apaf-1 and ATP is called as 
Apoptosome which initiates caspase-3 cascade activation (Elmore, 2007). 
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Figure 1.1 Extrinsic & Intrinsic Apoptotic Pathways (molecularbrain.com) 
1.6 Necrotic Cell Death 
Cell death is thought to occur primarily by two different modes, Apoptosis and Necrosis. 
Apoptosis is a programmed cell death whereas Necrosis is an unordered and accidental 
form of cell death (Farber, 2002).  Necrotic cells exhibit different morphological features 
than that of apoptotic cells such as plasma membrane rupture, spillage of intracellular 
proteins and  dilation of cytoplasmic organelles (Cookson et al, 2005). Induction of 
immune amplification is often shown by necrotic cells, which is in contrast to apoptotic 
cells (Kroemer et al, 2008). 
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It was thought for a long time that necrotic cells do not exhibit any markers but in recent 
literature many markers have been shown to play a role in necrosis. RIP1, which is a 
Serine/threonine kinase receptor- interacting protein, is thought to play a role in initiation 
of necrosis (Vandenabeele et al, 2007). Irrespective of the stimuli, ROS (reactive oxygen 
species) and calcium play an important role in necrosis. ROS initiates DNA damage, loss 
of lipids and proteins which further causes loss of membrane integrity (Vandenabeele et 
al, 2008).   
Death receptors such as the TNF Receptor-1 (TNF- RI) have shown the ability to initiate 
caspase-independent cell death. This form of necrotic death is due to the generation of 
ROS. This generation of superoxide formation is dependent on the NADPH oxidase 
which forms complexes with the adaptor molecules such as TRADD (Liu et al, 2008). 
1.7 Mitotic Catastrophe 
Mitotic catastrophe is generally defined as an abnormal form of mitosis which involves 
many morphological and biochemical changes leading to cell death (Zhivotovsky, 2008). 
Mitotic catastrophe is characterized by some distinct morphological features which are 
mainly micronucleation or multinucleation. Micronucleation is generally a product of 
faulty chromosome fragmentation. These fragments are the result of uneven distribution 
of chromosomal material between daughter nuclei. Multinucleation can result due to 
abnormal karyokinesis. (Vakifahmentoglu et al., 2008, Galluzzi et al., 2011). 
Biochemical signals which are involved in mitotic catastrophe are yet not clear but there 
are some processes which are activated for this phenomenon, which includes 1) 
activation of caspase-2, (Zhivotovsky et al., 2008, Galluzi et al., 2011) 2) long lasting 
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activation of SAC (Spindle- assembly checkpoint) (Galluzzi, 2011) which prevents 
anaphase causing chromosome missegregation, 3) High levels of cyclin B1, (Galluzzi et 
al., 2011) and 4) induction of TP53 (Tumor Suppressor protein activity) (Vitale et al., 
2011, Galluzzi et al., 2011). There are at least two subtypes of mitotic catastrophes. The 
first subtype occurs in a p53 independent manner where cells die during or near 
metaphase. In the second subtype, failed mitosis can lead to activation of mitotic 
catastrophe during activation of the polyploidy check point. This is partially p-53 
dependent. (Galluzzi et al., 2011). It is still unclear if mitotic catastrophe requires caspase 
activation exclusively. 
1.8 Senescence 
In 1961, Hayflick first described the fundamental cell response of cellular senescence 
(Stewart et al, 2008, Hayflick & Moorhead., 1961). Replicative senescence is the 
phenomenon which prevents normal cells from multiplying indefinitely (Campisi,. 2000). 
Senescence is also induced by different stresses such as DNA damage by radiation 
(Stress induced, premature or accelerated senescence) and telomerase shortening (Ben-
Porath, 2004). In stress induced senescence, one form of stress can be in the form of 
oncogene induces stress. Oncogenes can induce and initiate senescence which is referred 
to as ‘Oncogene induced senescence’ (Collado and Serrano, 2006). Activated oncogenes 
such as H-Ras play an important role in oncogene induced senescence (Neil et al, 2008). 
H-Ras is responsible for inducing cell cycle arrest when they are introduced alone. 
Oncogene induced senescence is dependent on the activation of the Raf-
1/MEK/p38MAPK pathway (Mason, Jackson and Lin, 2004). 
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Senescent cells show a typical ‘Senescent Phenotype’ which involves changes in gene 
expression, growth arrest and generally resistance to cell death signals (Campisi., 2007).  
Senescence growth arrest is regulated primarily by two tumor suppressor proteins, p53 
and  pRb. In the p53 pathway, where p53 is induced by stimuli such as ionizing radiation, 
activation of p53 is achieved by ATM/ATR and Chk1/Chk2 proteins (Ben- Porath, 2005). 
p21 is a very crucial protein in this pathway, acting as a transcriptional target of p53 and 
as mediator of p53 induced senescence. Another pathway involves p16 and 
phosphorylation of Rb and E2F expression. These two pathways work partially together 
but can also work independently as indicated in the review by (Campisi., 2007). 
 
Figure 1.2 Senescent Pathways: Regulated mainly by p53, p21, Cdk2. (Ben- Porath, 
2005). 
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Figure 1.3 Senescent Pathways: Regulated mainly by p53, p21, Cdk2. (Campisi et al, 
2006) 
1.9 Autophagy 
Autophagy, a process that occurs in all eukaryotic cells is responsible for long lived 
proteins degradation as well as organelle turnover (Wen Wang and Klionsky, 2003). 
Autophagy is an evolutionary conserved process in which cellular organelles are 
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degraded. They are further reused and thus energy is conserved (N. Chen and Karantza- 
Wadsworth, 2009). Autophagy begins with separation of a portion of the cytoplasm and 
cell organelles by a unique isolation membrane.  This isolation membrane extends itself 
to form a double membrane ‘Autophagosome’. The autophagosome further fuses with 
lysosome to form a single membrane structure the ‘Autophagolysosome’.  Lysosomal 
ezymes are responsible for degradation of the content of the autophagolysosome 
(Mizushima, 2007). Multiple cellular and molecular events are required for the autophagy 
process. Several autophagy proteins are required for elongation and formation of the 
autophagic membrane. Upon various cellular stresses such as DNA damage or nutrient 
deprivation autophagy is activated. Various autophagy related genes (ATGs) are required 
for activation and elongation of the autophagosome. One of the protein which plays 
important role is Light chain protein (LC3) which is required for the stabilization of the 
autophagosome. Upon autophagy activation, LC3 I is converted to LC3 II by E-1 like 
enzymes ATG7 (Tanida et al., 2008). Another ubiquitin- binding protein, p62, plays an 
important role in the autophagy process. p62 binds to LC3 and is degraded, which 
indicates autophagic flux. Thus, upon autophagy induction p62 levels are decreased 
(Johansen et al., 2009).  Upon the formation of the autophagolysosome (after fusion of 
autophagosome and lysosome), cellular contents are degraded and are used as substrates 
for synthesis of amino acids which are further used for the synthesis of important 
macromolecules (Geng and Klionsky, 2008). 
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Figure 1.4 Autophagy process: Reference: T. Vellai (Autophagy genes & Ageing) 
Autophagy is generally thought to be a cell survival mechanism. Upregulation of 
autophagy can work as a tumor cell survival mechanism under conditions such as stress 
(Eskelinen, 2011). There is also data which shows that autophagy also can lead to cell 
death when apoptosis is defective (Kroemer et al., 2005). Autophagy is induced upon 
radiotherapy and upon treatment with various cytotoxic agents (Koukourakis et al, 2009) 
and can act as mode of cell death or as a mechanism of resistance (Gewirtz et al, 2008). 
In order to demonstrate that autophagy is mediating cell death, prevention of death must 
be shown using pharmacological or genetic inhibition of autophagy (Shen et al, 2011). 
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1.10 Previous Studies 
Previously, our laboratory has demonstrated that vitamin D can enhance the response to 
radiation and analogues of vitamin D can be used to sensitize cells to radiation 
(Demasters et al, 2006). Radiosensitization caused by vitamin D was not mediated 
through apoptosis or mitotic catastrophe; instead autophagy was likely the mode of 
sensitization. (Demasters et al, 2006). In a recent paper, our laboratory has demonstrated 
the existence of both cytoprotective and cytotoxic autophagy in the same experimental 
system where autophagy induced by radiation alone was cytoprotective and upon 
treatment with radiation + vitamin D, cytotoxic autophagy mediated the effects in ZR-75-
01 breast cancer cells (Wilson et al, 2012). 
Although it has been shown that both MCF-7s and ZR-75-01 breast tumor cells can be 
sensitized to radiation upon autophagy inhibition, it is not necessarily the case that, all 
breast cancer cells exhibit sensitization upon autophagy inhibition. Studies performed on 
4T1 cells in our laboratory established that genetic or pharmacological autophagy 
inhibition did not increase radiation sensitivity in vitro or in vivo (Bristol et al, 2012, 
under revision in press).  
Recently the targeting of cytoprotective autophagy in order to overcome resistance has 
become a potential therapeutic approach (Kondo et al, 2005). A number of studies have 
been performed in cell culture and animal models in order to enhance sensitivity to 
treatment and clinical trials are in progress (Amaravadi et al, 2007, Jiang et al, 2010). 
In the current work, all studies have been performed on Hs578t cells, which are a model 
of triple negative breast cancer. In previous studies of the effects of radiation on colony 
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formation, Hs578t cells were established to be significantly less sensitive to radiation 
than MCF-7 cells (Bristol et al, 2012). Upon exposure to either radiation alone or 1,25 D3 
alone, Hs578t cells did not undergo apoptosis; however, induction of apoptosis was 
observed when cells were treated with the combination of radiation and 1,25 D3. 
Autophagy induction as well as induction of autophagic flux was shown using acridine 
orange staining and p62 degradation respectively upon radiation (Bristol et al, 2012). 
Autophagic flux can be an indicative of completion of autophagy.  
1.11 Hypothesis 
Since preliminary studies demonstrated that autophagy was occurring in Hs578t cells, the 
current work was designed to determine if radiation induced autophagy is cytoprotective 
or cytotoxic. In cytoprotective autophagy, cell viability is reduced when autophagy is 
inhibited (Chiou et al, 2012, Bristol et al, 2012, Wilson et al, 2012). To evaluate if 
autophagy is mediating the cytotoxic effects of treatment, upon inhibition of autophagy 
cell number should be restored and cells should recover proliferative capacity. 
Interference with cytotoxic autophagy should be able to reduce radiation sensitivity 
(Wilson et al, 2012) 
The following hypotheses were proposed: 
1. Cytoprotective autophagy is a general response of breast cancer cells to radiation. 
2. Inhibition of autophagy will sensitize breast tumor cells to radiation. 
The following aims were established: 
 To study if irradiation induces autophagy in Hs578t cells 
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 To evaluate if Hs578t cells are radiosensitized upon autophagy inhibition 
 To determine what modes of growth arrest or cell death might be involved in the 
response to radiation in Hs578t cells. 
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SECTION 2: MATERIALS AND METHODS 
2.1 Materials 
MEM Alpha medium containing L-Glutamine was obtained from Invitrogen (Grand 
Island, NY) Trypsin-EDTA (0.25% Trypsin, 0.53mM EDTA- 4Na) was obtained from 
Fisher. Fetal Bovine Serum was purchased from Hyclone Laboratories (Logan, UT). 
TUNEL Assay reagents (terminal transferase, reaction buffer, and CoCl2 and fluorescein 
dUTP) were purchased from Roche (Manhein, Germany). Annexin PI and Propidium 
Iodide were purchased from BD Biosciences (San Diego, CA). Trypan Blue, Acetic Acid, 
Acridine Orange, Formaldehyde and DAPI reagent (6- Diaimidino 2- Phenylindole), 
were purchased from Invitrogen (Eugene, Oregon, USA). PBS (pH 7.4) was purchased 
from Gibco (Life Technologies, NY USA). X-Gal (5- bromo-4- chloro-3- for β-
Galactosidase staining assay was purchased from Fermentas Life Sciences (Made in EU). 
2.2 Cell Lines 
Hs578t mammalian breast tumor cells were obtained from ATCC and kept under liquid 
nitrogen in 10% DMSO (Sigma Chemicals, St. Louis, MO) with 10% Fetal Bovine 
Serum (Serum Source International, Charlotte NC USA) until use. 
2.3 Cell Culture & Treatment 
Hs578t cells were grown from frozen stock in MEM-Alpha supplemented with 20% FBS 
and penicillin/streptomycin (0.5ml/100ml medium). Cells were cultured in T75 flasks 
(Cellstar) and were maintained at 37
0
C under a humidified 5% CO2 atmosphere.  Cells 
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were passed at 80% confluence after washing once with 1X PBS (Gibco) harvested with 
0.25% Trypsin-EDTA for 4-5 minutes and then deactivated with complete MEM Alpha 
medium. Cells were collected and centrifuged at 2000 rpm for 5 minutes (Centrifuge 
5810 R 
G
18.0).  Medium was aspirated and fresh medium was added to the cell pellet. 
Cells were suspended in the media and 400µl of cell suspension was added in T75 flask 
with 10ml complete MEM Alpha media. Cells were plated and allowed to adhere to the 
plate overnight under incubation.  All plates with cells were examined for bacterial and 
fungal infections prior to experiments. 
2.4 Drug preparation & Treatment 
Chloroquine (CQ) was obtained from Sigma (St. Louise, MO). A stock solution was 
prepared by suspending CQ in pure water. A stock concentration of 50mM was made and 
stored at -20
0 
C.  3-methyladenine (3MA) was obtained from Sigma (St. Louise, MO) and 
dissolved in PBS by heating. A stock solution of 150mM was prepared and refrigerated. 
Hs578t cells were treated with a dose of 5 х 2Gy given over a period of 3 days.  
Chloroquine or 3MA were added 3 hours before radiation and cells were maintained in 
the presence of CQ or 3MA until radiation was completed. Media was replenished once 
treatment was terminated. 
2.5 MTT Assay 
The MTT assay was used to determine the effective dose of Chloroquine and 3MA for 
further experiments. For the MTT assay, cells were plated in 96 wells plate at a density of 
5000 cells /well in 200µl of MEM Alpha medium. Cells were allowed to adhere to the 
plates overnight and then treated with different doses of Chloroquine and 3MA. CQ doses 
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used ranged from 2.5µM- 50µM and 3MA was tested over the range of 2.5mM – 25mM.  
Cells were incubated with drug for 72 hours; then media was then aspirated and cells 
were incubated with the MTT solution (2mg/ml PBS) in each well for 3 hours at 37
0 
C. 
The MTT solution was removed, 100µl of autoclaved DMSO was added and plates were 
shaken for 10 min. In the MTT assay, the MTT (3-(4, 5- dimethylthiazol -2- yl)-2, 5- 
diphenyltetrazolium bromide reagent is reduced by enzymes in living cells to formazan.  
DMSO acts as solubilizing solution dissolving insoluble purple formazan product into a 
colored solution. 
2.6 Cell Viability 
Cell Viability was measured using Trypan Blue exclusion. Trypan Blue is an exclusion 
dye that does not stain cells which have an intact cell membrane. Cells were plated in 
triplicate at a density of 10,000 cells/well and were allowed to adhere overnight. Cells 
were then treated with CQ or 3MA for 3 hours and/or followed by 5х2Gy radiation. 
Media was replenished once irradiation was completed and cells were counted at various 
time points. Cells were incubated with trypsin (0.25% Trypsin-EDTA) for 5-10 min and 
stained with Trypan Blue (0.4% Trypan Blue). Cells were counted using a 
haemocytometer with phase contrast microscopy on Day 1, 3, 5 and 7 post radiations. 
2.7 Clonogenic Survival Assay 
The Clonogenic survival assay evaluates the ability of single cells to form colony. Cells 
were plated in triplicate typically at a density 100 cells/well. 10-14 days after treatment, 
cells were fixed with 100% methanol, air dried and stained with 0.1% v/v Crystal violet 
(Sigma 3886). 
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2.8 Acridine Orange Staining Assay for Autophagy 
The volume of the cellular acidic compartment is increased in autophagy and hence 
staining of the acidified autophagosome is used as an autophagy marker. (Paglin et al., 
2001) Cells were plated and treated as described for the cell viability assay.  At various 
time points (the same time points at which cells viability was determined), cells were 
treated with 0.4µM Acridine Orange (Invitrogen A3568) in medium and incubated for 15 
minutes. Cells were then washed with 1X PBS, fresh media was added and fluorescent 
micrographs were taken using an inverted fluorescence microscope (Olympus). Increased 
numbers of acidic vesicular organelles were observed using at least three replicates per 
condition per time point. 
2.9 Beta Galactosidase Staining Assay for Senescence 
Senescence is a state of cellular growth arrest.(Serrano M. et al., 2007) In senescent cells 
the beta galactosidase enzyme is upregulated and cleaves the X-Gal substrate. Cells were 
plated and treated as indicated in the cell viability assay.  
At various time points (again, the same times at which cells were counted for viability), 
cells were washed with 1X PBS, fixed with 2% formaldehyde and 0.2% Glutaraldehyde 
for 10 minutes followed by a wash with PBS. Cells were then incubated in a CO2 free 
incubator with staining solution. A CO2 free incubator is essential in order to maintain pH 
at 6. The staining solution or staining buffer for the beta galactosidase assay contains 
20mg/ml X-Gal in dimethyl formaldehyde, 0.2M citric acid/Na phosphate buffer at pH 6, 
100mM potassium ferrocynide, 100mM Potassium ferricynide, 5M NaCl, 1M MgCl2 in 
distilled water.   The senescence signal can be observed as early as 2 hours after 
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incubation but for best results overnight incubation was preferred. Cells were washed 
with PBS and images were captured using light microscopy. 
2.10 DAPI staining Assay 
DAPI (4’6, diamidino-2-phenylindole) is a fluorescent stain that binds tightly to DNA in 
A-T rich regions. It is used as a nuclear marker to detect DNA fragmentation.  Cells were 
collected at specific time points and were centrifuged at 5000 rpm (G 18.0), for 5 
minutes. Slides with these cells were made by spinning cells at 10,000 rpm for 5 minutes 
in a Shandon Cytospin 4 (Thermal Electron Corp). Slides were refrigerated until ready 
for staining. On the day of staining, slides were washed 2X with PBS for 5 minutes at 
room temperature. Cells were fixed on slides using a 1:2 dilution of acetic acid: ethanol at 
20
0
 C for 5 minutes.  Slides were again washed with 1X PBS for 5 minutes. Slides were 
prepared with 10μl of a 1:1000 dilution of Vectashield. Coverslips were fixed to slides 
using clear nailpolish and micrographs were taken using an Olympus SC 35 Type 12 
camera. 
2.11 TUNEL Assay (Terminal deoxynucleotidyl transferase dUTP nick 
end labeling) 
The TUNEL assay is widely used to distinguish between apoptotic cells where DNA is 
fragmented and normal healthy cells. Fluorescein is inserted at the 3’-OH terminal of 
fragmented DNA with the help of the enzyme terminal transferase.  The method of 
Gavrieli et al. 1992 was used and fragmented DNAs in cells undergoing apoptosis was 
detected using an In Situ Detection Kit (Roche 03 333 566 001). Cells that had been 
treated were examined at various time points by fixation on slides using Cytospin 4 
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(Shandon) and were stored at 4 0 C until ready for staining. For staining, cells were fixed 
by immersing in a 4% formaldehyde solution for 10 min at room temperature followed by 
2X wash with PBS for 5 min each. Slides were then immersed in 1:2 mixture of Glacial 
acetic acid: Ethanol for 5 min at room temperature. 2X PBS washes were followed. Using 
an ImmunoPen (CaliBiochem, San Diago, CA) tight circles were drawn around cells. 
Cells were blocked then using 1mg/ml of Bovine Serum Albumin for 30 min at room 
temperature followed by 2 washes at room temperature with PBS for 5 min each. Cells 
were then incubated at 37
0
C for one hour using an enzyme mix which contained 4µl of 
5X reaction buffer, 0.2µl of Terminal Transferase, 2µl of 25 mM COCl2, 0.4µl of 
fluorescein-12-dUTP and 13.4µl water per sample.  Slides were washed twice with PBS 
at room temperature, coverslips were placed on slides using clear nailpolish and 
micrographs were taken using an Olympus inverted microscope. All images presented are 
at the same magnification. 
2.12 Western Blot Analysis 
Cells were harvested and treated as for the cell growth survival assay. Cells were plated 
typically at a cell density of 50,000-100,000 cells per 10mm cell culture dish. After 
treatment, cells were washed with PBS and lysed using 500-600µl lysis buffer. (1:100 
Phosphatase inhibitors and 1:50 protease inhibitor in M-PER lysis buffer) (Thermo 
Scientific # 78501). Protein concentrations were determined by the Bradford method 
using Bradford reagent (Bio- Rad 500-0205). Equal aliquots of 25µg were separated 
using 12% Mini PROTEAN Pre-Cast Gels (Bio Rad). Proteins were transferred onto 
PVDF membranes (soaked in methanol) using transfer buffer (200ml methanol, 100ml 
10X tris/glycine & 700 ml water) (Bio Rad 161-0732). After protein transfer, the 
 24 
membrane was blocked using a blotto mixture comprised of 5% skim milk powder and 
0.1% Tween-20 made up in 1X PBS. After blocking the membrane was incubated with 
the primary antibody overnight followed by three washes with 1X PBS. The membrane 
was then incubated with the secondary antibody for 2 hours followed by a wash with 1X 
TBPS. The membrane was developed using West Femto Maximum Sensitivity Substrate 
(Thermo Scientific # 34095) and Premium Quality X-Ray films (PHENIX). Primary 
antibodies were diluted in blotto at a 1: 1000 dilution and secondary antibodies were 
diluted at 1:5000 dilutions. Primary antibodies were used anti-p62 (Santa Cruz SC-
28359) and antiβ-action (Santa Cruz) was used. The secondary antibody was anti-mouse 
(Santa Cruz SC- 2005 Lot A2312). 
2.13 FLOW Cytometry Analysis 
2.13.1 FACS analysis using Annexin V – PI staining to determine apoptotic 
and necrotic cells 
FACS analysis was performed in order to determine and quantify the extent of apoptosis 
and necrosis in Hs578t cells. For FACS analysis, treated cells were collected and labeled 
fluorescently using a FITC Annexin V apoptosis detection kit I (BD Biosciences Lot # 
556547). Labeling was done by adding 500µl of binding buffer, 5µl Annexin V- FITC 
and 5µl Propidium Iodide to each sample. Samples were mixed gently and incubated in 
the dark for 15 min. Increased Annexin V- PI labeled cells were measured by Flow 
Cytometry and analyzed by BD FACS Canto II and BDS DIVA software. A minimum of 
10,000 cells were counted within gated region. 
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2.13.2 FACS Analysis of Acridine Orange Staining to quantify the extent of 
Autophagy 
Treated cells were collected at specific time points and suspended in 500µl PBS. Cells 
were then stained with Acridine Orange stain (Invitrogen A3568) in 1:10000 dilution in 
PBS for 10 min; cells were then analyzed using by BD FACS Canto II and BDS DIVA 
software. A minimum of 10,000 cells were counted for the each gated region. 
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SECTION 3: RESULTS 
3.1 Effect of fractionated radiation on growth and survival of Hs578t 
breast tumor cells 
Radiation is widely used as a primary treatment for breast cancer. Patients receive 
multiple small doses of radiation (2 Gy), up to 40 Gy of a total radiation dose; therefore 
the use of fractionated radiation is clinically relevant. Previous studies in our laboratory 
have demonstrated that a dose of 5 × 2Gy arrests breast cancer cells without killing cells 
and that autophagy inhibition can sensitize breast cancer cells to radiation (Bristol et al, 
2012). 
Cells were irradiated with a 5×2 Gy of radiation over a period of 3 days and viable cell 
number was determined using trypan blue exclusion. Cells were counted on Days 1, 3, 5 
& 7 post-radiation. 
Fig 3.1 indicates that irradiated cells undergo an apparent growth arrest without cell death 
at all days. Although cell numbers appear to decline between from Day 0 to Day 1, this 
decline is not significant. 
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3.2 Induction of autophagy by radiation 
3.2.1 Measurement of induction of autophagy using Acridine Orange staining 
Previous studies in our laboratory have shown that upon radiation breast tumor cell lines 
such as MCF-7s undergo autophagy and upon inhibition of such autophagy, cells are 
sensitized to radiation. (Bristol et al, 2012). This approach can theoretically be used in 
order to increase the efficacy of the radiation therapy. 
Figure 3.1 Effect of fractional radiation on viable cell number 
Viable cell numbers were determined by Trypan Blue Exclusion. Irradiation dose= 5×2 Gy. 
Tukey. *≤0.05 as compared to control cells after One way ANOVA. Given results are 
representative of three experiments. 
 
 
* * 
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In order to study if irradiation induces autophagy in Hs578t cells, irradiated cells were 
stained with Acridine Orange and micrographs were taken at various time points using an 
inverted fluorescence microscope.  
Acridine Orange staining is widely used to identify cells undergoing autophagy. Acridine 
orange is a lysomotropic dye which accumulates in acidic organelles in a pH dependent 
manner. Acidic organelles are present in all cells but they are accumulated in cells 
undergoing autophagy. At physiological pH, acridine orange is a green fluorescent 
molecule but within an acidic environment it becomes protonated and is trapped in acidic 
vesicles, and emits bright red fluorescence (Klionsky et al, 2007).  
Irradiated cells clearly showed increased acridine orange staining and thus extensive 
induction of autophagy upon radiation as compared to control cells as indicated by Fig 
3.2. To understand the extent of autophagy it should be quantified. Serum starved cells 
were used as positive control. 
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 Figure 3.2 Induction of autophagy upon radiation 
Cells were irradiated using fractionated radiation administered over the course of 3 days 
with a minimum 6 hour interval between two doses (5×2Gy). Cells were stained with 
Acridine Orange and observed under an inverted fluorescent microscope (20X) on Days 1, 
3, 5 & 7 post radiation. Given images are representative of three experiments. 
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3.2.2 Quantification of acidic vesicular organelles (AVOs) using Flow 
Cytometry 
In order to quantify the extent of autophagy induced in irradiated cells, Flow cyometry 
analytical techniques were used. Cells were analyzed at the same time points as that of 
the viable cell count assay. 
Fig 3.3 indicates that irradiated cells show a significant increase in accumulation of acidic 
vesicular organelles from day 3 to day 5 post radiation whereas the extent of autophagy is 
reduced by day 7. 
 
 
 
Figure 3.3 Quantification of radiation induced autophagy 
Cells were irradiated with fractionated radiation (5×2GY) and media was replenished once 
radiation was completed. Cells were then analyzed using Flow cytometry on days 1,3,5 and 7 
post radiation. ANOVA was used followed by Tukey, *p<0.05. The extent of autophagy is 
significantly increased over controls at all time points. 
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3.2.3 Degradation of p62 indicating autophagic flux upon radiation of Hs578t 
cells 
A classic approach to understand if autophagy is going to completion is to monitor 
degradation of the p62 protein. p62 is a  multifunctional- ubiquitin- binding  scaffolding 
protein which is degraded with induction of autophagic flux and thus plays an important 
role (Johansen et al, 2009). LC3 acts as a receptor for p62. Ubiquitin protein p62 binds to 
LC3 in order to facilitate its degradation in autophagy. LC3 II is a microtubule associated 
protein which is converted from LC3I to LC3 II when autophagy is induced (Johansen et 
al, 2009). Thus, LC3 and p62 are both autophagy associated proteins and widely used as 
markers for autophagy. 
Western blot analysis was performed to probe for p62. Serum starved cells were used as 
positive control. Fig 3.4 indicates irradiated cells showed almost complete degradation of 
the p62 protein as compared to control cells indicating that autophagic flux is occurring. 
Serum starved cells also show almost complete degradation of p62. 
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Figure 3.4 Assessment of p62 degradation by Western Immunoblot 
Protein extracts were analyzed by western immunoblot analysis, Proteins collected on day 4 were 
analyzed using 10% gels. Actin was used as a loading control. N=2 
 
 32 
3.3 Inhibition of autophagy 
3.3.1 Determination of CQ dose and 3MA dose 
Previous studies in our laboratory have shown that autophagy inhibition can sensitize 
breast cancer cells to radiation (Bristol et al, 2012). 
Autophagy inhibition can be achieved using pharmacological or genetic approaches.         
Pharmacological inhibitors such as Chloroquine and 3MA (3- Methyl Adenine) are 
commonly used to inhibit autophagy (Rodemann et al, 2011). Chloroquine is a 
lysomotropic agent which accumulates in the lysosome and interferes with the 
acidification of the lysosome. (Solomonand and Lee, 2009).  It inhibits autophagy by 
interfering with the fusion of the lysosome with the autophagosome and inhibits 
formation of the autophagolysosome. 3MA is a PI3 kinase inhibitor (Bursch et al., 1996) 
that inhibits autophagy at a very early stage by interfering with the formation of the 
autophagosome. 
In order to inhibit autophagy using the pharmacological agents CQ and 3MA. The MTT 
assay was used to determine the concentrations of autophagy inhibitors that would have 
limited toxicity. Cells were exposed to drug for 72 hours since irradiation is carried out 
for 3 days and were analyzed by measuring absorbance at 540nm. The MTT assay 
indicated that 3MA concentrations of 2.5mM and 5mM are relatively nontoxic. Thus, a 
5mM dose (Fig 3.5) was selected for further treatments. 
Likewise, cells were treated with CQ for 72 hours and cell viability was measured using 
the MTT assay and a concentration 25µM (Fig 3.6) was selected for further treatments. 
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Figure 3.5 Determination of 3MA dose 
Viability of cells after 72 hours of treatment with 3MA was measured using the MTT assay. Cells 
were plated in triplicate and exposed to increasing concentrations of 3MA. After 72 hours of 
incubation, 2mg/ml MTT was added to the plate for an additional 3 hours of incubation. The blue 
MTT formazan was then dissolved in 100µl DMSO. The absorbance was measured at 540nm 
using a multi plate reader. Cell viability was measured using the absolute absorbance at (540nm) 
n=3 
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3.3.2 Autophagy induced by radiation can be inhibited by Chloroquine (CQ) 
25µm 
In order to determine if autophagy can be successfully inhibited by CQ, Acridine Orange       
staining was performed in Hs578t cells with radiation alone and with the combination of 
IR and CQ. Chloroquine is a lysomotropic agent. It is a basic compound which interferes 
Figure 3.6 Determination of CQ dose 
Viability of cells after 72 hours of treatment with CQ was measured using the MTT assay. Cells 
were plated in triplicate and exposed to increasing concentration of 3MA. After 72 hours of 
incubation, 2mg/ml MTT was added to the plate for an additional 3 hours of incubation period. 
The blue MTT formazan was then dissolved in 100µl DMSO. Wavelength 540nm. n=3 
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with the acidity of the lysosome resulting in yellow colored vesicles when cells are 
exposed to acridine orange instead of the normal bright red staining in acidic 
compartments. Fig 3.7 shows that autophagy induced by radiation is inhibited by CQ 
treatment. This is confirmed in figure 3.4, where degradation of p62 induced by radiation 
was markedly decreased by CQ indicating successful inhibition of autophagy by CQ. 
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IR + CQ Day1 
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IR + CQ Day3 IR + CQ Day 5 
IR + CQ Day 7 Serum Starved 
Figure 3.7 Inhibition of autophagy using CQ 
Cells were pre-treated with CQ (Chloroquine) (25µm) 3hours prior to radiation (Radiation dose= 
5× 2Gy) and were treated with CQ throughout the irradiation period. Cells were incubated with 
Acridine Orange stain for 10 min. (1:10000). Images were captured using an inverted 
fluorescence microscope under 20X and are representative of three experiments. 
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3.3.3 Autophagy induced by radiation can be inhibited by 3- Methyladenine 
(3MA) 5mM 
Another pharmacological inhibitor, 3MA, was used to confirm the observations obtained 
in studies with CQ. 
Hs578t cells were treated with 3MA for 3 hours prior to irradiation and were maintained 
in the presence of 3MA throughout the radiation period. 3MA acts at an early stage of 
autophagy and interferes with the formation of autophagosomes via inhibiting PI3K. 
Cells exhibit a different staining pattern when exposed to acridine orange in the presence 
of 3MA. Due to inhibition of the formation of the autophagosome, one will expect to see 
less acridine orange staining if autophagy is inhibited. When cells were treated with the 
combination of IR and 3MA, a decrease in acridine orange staining indicated that 
autophagy induced by radiation was inhibited which is shown in Fig 3.8. Serum starved 
cells were used as a positive control for acridine orange staining. So far, it can be said 
that irradiation induced autophagy can be successfully inhibited by using 
pharmacological inhibitors Chloroquine and 3-Methyladenine. Serum starved cells are 
used as a positive control, since starved cells induce high levels of autophagy to survive 
and generate metabolic precursors.  
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Figure 3.8 Inhibition of autophagy by 3MA (3-Methyladenine) 
Autophagy was monitored using acridine orange staining. Radiation and combination of radiation 
and 3MA (3MA dose= 5mM) was used for treatment. Images were captured using an inverted 
fluorescence microscope under 20X and are representative of three experiments. 
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3.4 Effect of autophagy inhibition on radiation sensitivity of Hs578t 
breast tumor cells 
3.4.1 Effect of the combination of IR and CQ on viable cell number 
In order to determine if inhibition of radiation induced autophagy sensitizes Hs578t cells 
to radiation, cells were irradiated with and without Chloroquine (CQ). The impact of 
treatment was measured by determining viable cell number. As shown in Fig 3.9, only an 
apparent additive effect of radiation and chloroquine was observed. Cells treated with the 
combination of IR and CQ show only slightly more growth inhibition than IR treated 
cells. Sensitization of Hs578t cell would be expected to exhibit a robust response to 
combination treatment. 
         
 
 
Figure 3.9 Analysis of the effect of inhibition of autophagy on radiation sensitivity using CQ 
Viable cell number after each treatment was measured by Trypan Blue exclusion. Radiation dose: 
5×2GY, CQ: 25µm. Results are from average of three experiments, each in triplicate. ANOVA 
was run followed by Tukey *≤0.05. 
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As shown in Figure 3.9, cells treated with CQ alone show about a 25% reduction in 
viable cell number as compared to control cells on day 5. Irradiated cells show about an 
80% reduction in cell population. As a combined effect, CQ+IR treatment causes about a 
95% reduction in the population indicating a lack of sensitization. 
3.4.2 Effect of autophagy inhibition on colony formation ability of Hs578t 
cells 
To further confirm the lack of sensitization of autophagy inhibition, a clonogenic survival 
assay was performed. A clonogenic survival assay is often used to measure the efficacy 
of radiation or chemotherapy treatment by observing the ability of single cells to form 
colonies and is thought to be sensitive. 100 cells were plated in each well and the ability 
of the cells to form colonies was measured after 10-14 days. 
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The clonogenic survival assay Fig 3.10 also clearly reflects additive effects when Hs578t 
cells were treated with the combination of IR and CQ. In classic cytoprotective 
autophagy, cells use autophagy as a mechanism for cell survival and consequently when 
autophagy is inhibited, cells die (mostly by apoptosis). In Figures 3.9 and 3.10 Hs578t 
cells exhibited lack of sensitization upon autophagy inhibition indicating that autophagy 
is not cytoprotective in this system. 
Figure 3.10 Clonogenic Survival Assay using CQ 
Clonogenic survival assay was analyzed 14 days post treatment. CQ dose= 25µm, 
Irradiation dose= 5×2 Gy. N=2 with similar results. 
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3.5 Effect of the autophagy inhibitor, 3MA (3-methyadenine), on the 
radiation sensitivity of Hs578t cells 
3.5.1 Effect of combination of IR and 3MA on viable cell number 
In order to confirm that if lack of sensitization occurs irrespective of the pharmacological 
inhibitor used, sensitivity studies were repeated with another pharmacological inhibitor 3-
MA. The treatment conditions were essentially identical to those for CQ. Cells were pre-
treated with 3MA 3 hours prior to irradiation and were treated with it throughout the 
irradiation period. Viable cell numbers were monitored using the trypan blue exclusion 
assay. 
Fig 3.11 shows that cells treated with 3MA alone showed growth inhibition as compared 
to control cells but 3-MA alone did not exhibit excessive toxicity. Cells treated with 
irradiation showed a significant decrease in cell numbers compared to control cells with 
growth arrest. Cells treated with the combination of IR and 3MA exhibited a similar 
pattern of growth inhibition and growth arrest as seen with IR and CQ treatment.  Lack of 
sensitization seemed to be independent of the pharmacological inhibitor. 
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Figure 3.11 Analysis of the effect of inhibition of autophagy on radiation sensitivity using 
3MA 
 
 
 
 
 
Figure 3.11 Analysis of the effect of inhibition of autophagy on radiation sensitivity using 
3MA 
 Viable cells were monitored using trypan blue exclusion. Radiation dose: 5×2GY, 3MA 
dose= 5mM, n=3 with similar results. 3MA dose= 5mM. No significance was observed 
when IR treated and IR + CQ cells were compared by One Way ANOVA. 
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3.5.2 Analysis of effect of 3MA on the colony formation ability of Hs578t cells 
upon radiation 
To verify the results obtained from the cell viability assay when 3MA was used with IR 
in Hs578t cells, a clonogenic survival assay was performed. Fig 3.12 shows that cells 
treated with 3MA alone showed about 10% inhibition as compared to controls. Irradiated 
cells showed an approximately 50% reduction in colony formation. Cells treated with IR 
and 3MA combination showed complete lack of sensitization by exhibiting essentially 
the same extent of loss of clonogenic survival as that of IR alone. 
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Figure 3.12 Clonogenic Survival Assay using 3MA 
Clonogenic survival assay was analyzed on day 14 after treatment. Irradiation Dose= 5× 
2Gy. N=2 with similar results. 
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3.6 Radiation induces minimal apoptosis in HS578t cells 
DAPI and TUNEL are widely used assays to determine apoptotic cells. With the use of 
Vectashield, DAPI (4, 6- Diamidino-2-phenylindole) and TUNEL staining can be 
performed on the same slides without interference. In normal cells, DAPI staining shows 
a uniform nucleus with a clear margin in contrast to apoptotic cells where the margin is 
not clear and  cell nucleus is distorted. 
One primary characteristic of apoptotic cells is the fragmentation of DNA (Tschopp et al, 
1993). In the TUNEL assay, fluorescent nucleotides are inserted at the 3’-OH end of 
fragmented DNA, which gives bright green fluorescence in apoptotic cells.  
It has been observed that if radiation induced autophagy is cytoprotective, then upon 
inhibition of autophagy, cells become sensitized to radiation and die by apoptosis. (Jin H 
et al, 2011, Bristol et al., 2012). Another important aspect of this study was to check if 
radiation alone induces any apoptosis in Hs578t cells in order to study the mode of cell 
death. 
Cells were irradiated and upon DAPI/TUNEL analysis, it was evident that Hs578t cells 
undergo minimal apoptosis upon radiation. Taxol (1µm for 24 hrs.) was used as a 
positive control for apoptosis as shown by Fig 3.14. 
Irradiated cells exhibit lack of increased fluorescence indicating lack of induction of 
extensive apoptosis. A minimal apoptosis is detected at days 5 and day 7. 
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Control 
IR Day 1 
IR Day 3 
IR Day 5 
IR Day 7 
TUNEL DAPI 
Figure 3.13 DAPI/TUNEL Analysis in irradiated Hs578t cells 
Cells were fixed to the slides using a Cytospin and were stained for DAPI and TUNEL using 
10 μm VectaShield in 1:10000 dilutions and Cell death detection kit (Roche). Radiation 
dose= 5Χ 2 Gy. N=3. Olympus Microscope was used 
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3.7 Effect of autophagy inhibition on the extent of apoptosis by 
TUNEL/DAPI 
. 
 
 
 
 
 
 
Day 3 
Day 1 
Control 
Day 10 
Day 5 
TUNEL IR 
TUNEL CQ+IR 
TUNEL CQ+IR 
TUNEL CQ+IR 
TUNEL IR 
TUNEL IR 
TAXOL 
Figure 3.14 TUNEL Analysis for apoptotic cells with IR +CQ 
Cells were fixed to the slides using a Cytospin and were stained for TUNEL using Cell death 
detection kit (Roche). Micrographs were taken using an Olympus Inverted Microscope. All 
images shown were taken at 20X and are representative of three experiments. CQ=25µm,  
IR=5 Χ2 Gy 
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Irradiated cells exhibited minimal apoptosis when analyzed using TUNEL/DAPI (Figure 
3.13). Inhibition of autophagy using CQ did not increase the extent of apoptosis in the 
cells (Figure 3.14), which is consistent with the cell viability assay observations where it 
shows a growth arrest pattern. This indicates that autophagy inhibition is not promoting 
cell death by apoptosis which can be an indication that autophagy and it is unlikely to be 
cytoprotective in this experimental system.  
3.8 Quantification of Apoptotic cells by Annexin V/PI Flow Cytometry 
To confirm that apoptosis in Hs578t cells by IR alone as well as by IR + CQ is minimal, 
the extent of apoptosis was quantified using Annexin/PI assay by Flow Cytometry. 
Annexin/PI staining indicates the number of cells in early as well as in late apoptosis and 
necrosis. Annexin V stains cells which are in early apoptosis stage. A living cell has PS 
(Phosphotidylserine) in its inner membrane; during apoptosis, PS is translocated to the 
outer membrane and Annexin V has high affinity for PS, and cells in early apoptosis will 
stain with Annexin V. (Sawai et al, 2011, miltenyibiotec.com). On the other hand, PI 
cannot cross an intact cell membrane; during late apoptosis cells have compromised cell 
membranes and consequently PI can easily pass across the cell membrane and stains 
DNA by intercalating between bases. Necrotic cell are stained by both Annexin V / PI 
whereas viable cells are stained by none of these reagents. (researcher.nsc.gov.tw). 
The extent of apoptosis is quantified by taking the sum of the two right quadrants which 
represent early and late apoptosis. 
 
 48 
 
 
Annexin V 
Q1 Necrosis Q2 Late Apoptosis 
Q4 Early 
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PI 
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Figure 3.15 Each quadrant indicates a cell condition in AnnexinV/PI staining. 
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IR Day 1 
IR Day 5 
IR Day 7 IR + CQ Day 7 
IR + CQ Day 5 
IR + CQ Day 1 
IR + CQ Day 3 
IR Day 3 
Figure 3.16 AnnexinV-PI staining in IR and IR+CQ treated cells. 
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Quantification of Annexin V/PI staining gave results expected based on the 
TUNEL/DAPI experiments. Irradiated cells showed about 15-18% of apoptotic cells 
whereas cells treated with the combination treatment of IR+CQ did not show any 
significant increase in percentage of apoptotic cells (Figure 3.16).  
Table 3.1 indicates viable cell number is each quadrant 
Table 3.1 Quantification of Annexin V/PI staining assay: Each Column represents 
average of three replicates of each condition 
           Necrosis Late Apoptosis Early Apoptosis Viable 
Con 7 2.76±0.56 0.40±0.07 3.62±0.64 93.20±1.18 
CQ 1 15.74±2.6 3.71±0.33 2.82±0.25 77.72±2.27 
CQ 3 12.29±0.33 1.26±0.18 3.49±0.66 82.95±0.51 
CQ 5 4.27±0.12 0.30±0.15 3.19±0.97 92.22±1.00 
CQ 7 2.40±0.25 1.27±0.16 8.48±0.44 87.84±.34 
IR 1 20.46±0.76 7.34±0.56 8.42±0.72 63.77±0.55 
IR 3 17.84±0.74 7.39±0.83 6.21±0.47 68.54±0.98 
IR 5 6.08±0.96 2.41±0.32 5.84±0.25 85.64±1.19 
IR 7 1.66±0.27 1.26±0.19 10.18±0.22 86.89±0.25 
IR+CQ1   13.73±0.95 3.64±0.64 11.57±0.59 71.05±0.93 
IR+CQ3 14.24±1.37 8.47±0.49 11.37±.87 65.92±1.25 
IR+CQ5 4.94±0.39 4.52±0.33 9.37±0.27 81.16±0.80 
IR+CQ7 1.8±0.30 1.05±0.23 9.84±2.12 87.11±2.00 
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Both TUNEL/DAPI and Annexin V/PI staining confirmed that there is no significant 
increase in apoptotic cells when autophagy was inhibited in Hs578t cells, indicating the 
absence of sensitization. There is overlap between apoptosis and necrosis but Annexin V/ 
PI staining helps in distinguishing between cells which are early apoptotic and late 
apoptotic. Irradiated cells seem to be dying by necrosis on day 1 and Day 3 which can be 
explained as the initial response to radiation. Irradiation induces about 9 -15% of 
apoptosis on all treatment days but the percentage of apoptotic cells did not increase at 
any time points when they were treated with the combination of IR + CQ.  
 
3.9 Irradiation of Hs578t cells promotes senescence 
The assay of viable cell number (Figure. 3.1) indicates that radiation treatment results in 
growth arrest which might be an indicative of senescence. The breast tumor cells might 
be undergoing senescence as an association between autophagy and senescence has been 
shown by others as well as by our laboratory (Goehe et al, 2012 in press). Cellular 
senescence is a form of stable cell cycle arrest with active metabolism (Young et al., 
2009). Beta-galactosidase staining is widely used assay to distinguish senescent cells 
from normal cells. In senescent cells, beta galactosidase is upregulated when these cells 
are treated with the chromogenic substrate X-gal; X-gal is cleaved by beta galactosidase 
and generates an insoluble blue compound at pH 6. (Toussaint et al., 2009) 
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Figure 3.17 Radiation induces senescence in Hs578t cells 
 
 
 
Irradiated cells clearly show blue staining from Day 1 to Day 5 post radiation confirming 
the presence of senescent cells as shown in Fig 3.17. Thus, it can be said that fractionated 
radiation induces senescence in Hs578t cells. Irradiation induced senescence was reduced 
by day 5 which establishes that autophagy and senescence might be related to each other. 
Irradiation induced autophagy is also reduced by day 7 which was shown using flow 
cytometry (Figure 3.3). 
Control  IR Day 1 
IR Day 3 IR Day 5 
Figure 3.17 Radiation induces senescence in Hs578t cells 
Irradiated cells were fixed and then stained on the indicated days and images were taken 
under normal white light microscope. Radiation Dose= 5× 2Gy. 
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3.10 Effect of autophagy inhibition on senescence induced by radiation 
Studies were performed to assess if there is any relationship between autophagy and 
senescence induced by radiation by determining whether autophagy inhibition altered 
senescence. The β-galactosidase assay was performed on cells treated with the 
combination of IR+CQ.  
Figure 3.18, indicates that Hs578t cells treated with IR+CQ did show reduced amount of 
beta galactosidase staining suggesting the possibility of a link between irradiation 
induced autophagy and senescence; that is when autophagy was inhibited, senescence 
was reduced. 
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IR  IR + CQ 
Day 1 
       Day 3 
Day 5 
Control 
Adriamycin 
Figure 3.18 Impact of autophagy inhibition on senescence in Hs578t cells using CQ.  
All micrographs were taken under white light inverted microscope. Radiation dose= 
5×2Gy. 20X, n=3. Cells treated with ADR (Adriamycin) were used as positive control.  
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3.11 Assessment of effects of 3MA (another autophagy inhibitor) on 
senescence 
In previous studies, 3MA has been used to inhibit autophagy. Assessment of the effect of 
3MA on senescence was performed using Beta-Galactosidase staining. 3MA seems to 
have the same effect as that of CQ on the extent of senescence. Although 3MA did not 
reduce extent of beta galactosidase staining as early as day 1, but from day 3 onwards it 
inhibited the amount of senescence in Hs578t cells. 
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Day 1 
Day 3 
IR IR + 3MA 
Figure 3.19 Impact of autophagy inhibition on senescence in Hs578t cells using 3MA  
3MA dose= 5mM. Radiation Dose= 5× 2Gy. 
 
 
 
Day5 
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3.12 Impact of single dose of radiation on Hs578t cells 
Hs578t cells do not appear to be sensitized to radiation upon inhibition of autophagy in 
contrast with other breast cancer cell lines such as MCF-7s. Another approach was taken 
to determine if a single dose of radiation sensitize cells to radiation upon autophagy 
inhibition.  Cells were irradiated with a 4Gy single dose of radiation. 
 
 
 
The same treatment paradigm was followed as fractionated dose. Viable cells were 
counted on respective time points using trypan blue staining. This experiment was 
performed to determine whether the radiation dose influenced susceptibility to autophagy 
Figure 3.20 Effect of single dose of radiation on cell survival when autophagy was inhibited. 
CQ dose= 25µm. Radiation Dose= 4Gy. 
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inhibition and sensitization. As shown in Fig 3.21, when cells were treated with single 
4Gy dose of radiation as compared to 5× 2Gy, growth was slowed but the cells did not 
actually arrest until between day 5 and day 7. Again, the combination treatment failed to 
indicate sensitization, but only an additive effect of IR + CQ was observed.  
3.13 Effect of single dose of radiation on colony formation ability of 
Hs578t cells 
When cells were treated with a single dose of 4 Gy radiation dose, the clonogenic 
survival assay showed in Fig 3.21 indicated complete lack of sensitization by CQ but 
only additive was shown.  
 
 
 
Figure 3.21 Clonogenic assay with single 4GY dose of radiation. CQ dose= 25µm. 
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SECTION 4: DISCUSSION 
Radiation therapy is widely used to treat various cancers. Irradiation causes extensive 
DNA damage and kills cancer cells (Masuda & Kamiya, 2011). The development of 
resistance and recurrence of disease are the primary limitations of radiation therapy. In 
order to overcome these limitations, combination therapy can be a beneficial approach.  
Upon irradiation, it has been found that breast tumor cells undergo autophagy (Rodemann 
et al, 2011). Autophagy is an evolutionary conserved catabolic process in which 
cytoplasm and other cellular organelles are recycled and reused (Przyklenk et al, 2010). 
Autophagy can serve as a defense mechanism to protect cells against DNA damage or it 
can act as a mode of cell death; however there is controversy as to the role of cytotoxic 
autophagy in chemotherapy and radiotherapy (Eileen White et al, 2010).  
In cytoprotective autophagy, autophagy acts as defense mechanism. Autophagy can be 
inhibited using different pharmacological or genetic approaches. CQ (Chloroquine), 3MA 
(3- Methyladenine) and Baf (Bafilomycin) are agents that are commonly used to inhibit 
autophagy pharmacologically (Rodemann et al, 2010, Zisterer et al, 2012). The 
combination of irradiation with an autophagy inhibitor can sensitize breast cancer cells to 
radiation (Bristol et al, 2012). Sensitization is a condition of supra additive effect where 
the total effect of two agents is greater than the additive impact of each of those agents 
individually (P.269-270,2nd edition, advances in radiation oncology in Lung cancer, 
Brady L.W., Heilmann H.P., Molls.M. Nieder.C.)  Sensitization of cells can be used as an 
approach to increase the effectiveness of treatment to tumor cells that develop resistance. 
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Previously it has been shown in our laboratory that MCF-7 and ZR-5 breast tumors can 
be sensitized to radiation when treated with an autophagy inhibitor such as Chloroquine 
(Bristol et al, 2012 and Wilson et al, 2012).  
About 12-17% of breast cancers are triple negative breast cancers (Reis & Fliho, 2010). 
Triple negative breast cancers do not respond well to established cancer treatments. 
Hs578t is a triple negative breast cancer cell line (Lehmann et al, 2011). Previous studies 
in our laboratory confirmed that Hs578t cells are relatively resistant to irradiation 
compared to other breast cancer cell lines such as MCF7 cells (Bristol et al, 2012). Our 
studies were performed using Hs578t cells to determine if sensitization to radiation could 
occur using a combination treatment of irradiation with an autophagy inhibitor (CQ).  
When Hs578t cells were irradiated with fractionated doses of 5х 2Gy, the irradiated cells 
showed a slight decrease in viable cell number but the primary response was growth 
arrest. Irradiated cells also demonstrated autophagy which was inhibited using CQ 
(Chloroquine) and 3MA. When Hs578t cells were treated with the combination of IR and 
CQ, there was no increase in sensitivity but merely an additive effect of IR and CQ 
indicating that autophagy may not be cytoprotective. Cells were arrested throughout the 
period. These observations were further confirmed using another autophagy inhibitor, 3-
MA, which also exhibited lack of sensitization.  
To check if autophagy inhibition exerts any effect on the extent of apoptosis, 
DAPI/TUNEL staining was performed on the cells treated with the combination of CQ 
and IR. Autophagy inhibition did not show any significant increase in cell death by 
apoptosis. The lack of increased apoptosis was further confirmed by using flow 
cytometry analysis with Annexin V/PI staining.  
 61 
Irradiation induced minimal apoptosis. Annexin/PI staining by Flow cytometry did show 
that the extent of apoptosis in irradiated cells was approximately between 15-18% 
whereas in control cells it was approximately between 5-10%. This clearly indicates that 
irradiated cells do not undergo apoptosis to a great extent. If autophagy is a pro-survival 
response then one might expect that upon inhibition of autophagy cells will die. (Bristol 
et al, 2012). 
In our studies, Hs578t cells show minimal apoptosis when exposed to radiation alone and 
furthermore apoptosis does not increase with autophagy inhibition. Cells also show lack 
of sensitization with merely additive effects using autophagy inhibitors. Irradiated Hs578t 
cells clearly show an increase in autophagic markers such as acridine orange staining as 
well as an increase in autophagic flux which was shown by p62 degradation. If autophagy 
is apparently not cytoprotective, then it might be playing a role in mediating cytotoxic 
effects of irradiation. Autophagy would be considered as being pro-death where 
inhibition of autophagy protects the cells from the radiation treatment (Gewirtz et al, 
2009). 
Cytotoxic autophagy where cells die by autophagic cell death without involvement of 
apoptosis or necrosis remains an unclear phenomenon, where debate continues if 
autophagy itself acts as a mode of cell death or just leads to some other form of cell 
death. Nevertheless, cytotoxic autophagy has clearly been indicated in some experimental 
systems such as in a study by Freundt et al, autophagic cell death has been reported 
which was induced by zVAD in limited number of cell types (Codogno et al, 2011). Such 
autophagy should demonstrate cell death occurs without apoptosis and suppression of 
autophagy pharmacologically or genetically should be able to rescue cell number. In the 
 62 
current system, cells are undergoing senescence and are not dying by apoptosis but at the 
same time cells are not rescued upon autophagy inhibition, indicating the absence of 
cytotoxic autophagy. 
The time course study of cell viability demonstrated a sustained growth arrest pattern, 
which can be an indication of senescence. To further asses the possibility of senescence, 
irradiated cells were analyzed for beta galactosidase staining. Irradiated cells clearly 
showed induction of senescence. 
Our laboratory has generated data that senescence and autophagy can be functionally 
dependent on each other (Goehe et al, in press). In Young et al (2009), it was reported 
that autophagy might be contributing to oncogene induced senescence. To verify if 
autophagy and senescence might be related in our experimental model, we investigated 
whether irradiation induced senescence has any relation with autophagy. Cells were again 
analyzed for beta galactosidase staining using the combinations of IR+ CQ and IR+ 
3MA. After treatment with the autophagy inhibitors, senescence was apparently 
decreased. This can be indicative that in Hs578t cells, autophagy and senescence might 
be closely related responses. Understanding the relationship between autophagy and 
senescence is important in this system in order to understand the mechanism behind 
resistance to radiation.  
Several experimental systems including cellular and animal models as well as clinical 
trials are in progress in order to study if sensitivity to chemotherapy or radiation 
treatment can be increased by using the autophagy inhibitor chloroquine or 
hydroxychloroquine ( Kelekar et al, 2007, Amaravadi et al, 2007). 
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Recently in our laboratory, it has been shown that 4T1 cells are not sensitized to the 
effects of radiation when autophagy was inhibited either in vivo or in vitro (Bristol et al, 
2012, in press).  
Another possibility of p53 status also should be taken into considerations, Hs578t do 
show different responses upon radiation which is not same as that of another breast 
cancer cell lines such as MCF-7s. MCF-7s are p53 wild type cells whereas Hs578t are 
p53 mutant cells which might be one of the basis for the different responses. 
Thus it can be said that cytoprotective autophagy may not be a universal response of 
breast tumor cells upon radiation. Since autophagy can play a role in tumor prevention or 
tumor survival studying the nature and role of autophagy in cancer is an important aspect 
of cancer research. 
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SECTION 5: FUTURE EXPERIMENTS 
In order to further study the role of autophagy in Hs578t cells, the effect of autophagy 
inhibition on radiation sensitivity using genetic approaches should be performed. To 
inhibit autophagy, atg5 or atg7 can be silenced using siRNA techniques. Loss of function 
of these genes essential for autophagy should result in autophagy inhibition.  
Such genetic inhibition should rescue cells if autophagy is cytotoxic and promote cell 
death if autophagy is cytoprotective. If genetic inhibition does alter the response to 
radiation in a significant way, then it can be concluded that pharmacological inhibition 
was nonspecific whereas genetic inhibition is specific.  
Effects of pharmacological inhibition suggested that cytoprotective autophagy may not be 
a general response in all breast tumor cells.  In our studies, CQ (Chloroquine) and 3MA 
were used as pharmacological inhibitors. 3-MA is PI3 kinase inhibitor which acts on 
class I as well as class III (Liu J et al, 2012). 3MA is known to act on both classes of 
enzymes. Effects of 3MA can be thus nonspecific as it can act on class I which inhibit 
mTOR and induce autophagy instead of inhibiting autophagy (Shen et al, 2011).  
In order to confirm that autophagy and senescence are correlated, quantification of beta 
galactosidase activity will be determined with irradiated cells treated with the 
combination treatment IR + CQ and IR + 3MA. 
Time course studies for p62 degradation as well as for p21 induction will help to 
establish the relationship between autophagy and senescence. 
Controversy in the literature continues whether autophagy is pro-survival or pro-death or 
can exist together. Our laboratory is currently interested in knowing what is the 
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difference between cytotoxic and cytoprotective autophagy. Our laboratory also focuses 
on the relationship between autophagy and senescence and if they are dependent on each 
other. A clear distinction between pro-survival and pro-death autophagy would be helpful 
in order to understand the multiple roles of autophagy. 
 
 66 
REFERENCES 
Amaravadi, R.K., Yu, D., Lum, J.J., Bui, T., Christophorou, M.A., Evan, G.I., Thomas- 
Tikhonenko, A., and Thompson, C.B. (2007). Autophagy inhibition enhances therapy 
induced apoptosis in a Myc-induced model of lymphoma. J. Clin. Invest 117, 326-336.  
American Cancer Society. (2012). External Radiation Therapy 
http://www.cancer.org/Treatment/TreatmentsandSideEffects/TreatmentTypes/Radiation/
UnderstandingRadiationTherapyAGuideforPatientsandFamilies/understanding-radiation-
therapy-external-radiation-therapy. .2012,  
American Cancer Society. (2012). Hormone Therapy for Breast Cancer 
http://www.cancer.org/Cancer/BreastCancer/DetailedGuide/breast-cancer-treating-
hormone-therapy.Aug 2012,  
American Cancer Society. (2012). Radiation Therapy for Breast Cancer 
http://www.cancer.org/Cancer/BreastCancer/DetailedGuide/breast-cancer-treating-
radiation.. 2012,  
American Cancer Society. (2012). Radiation Therapy principles.2012,  
ATCC. Triple Negative Breast cancer Cell Panels.2012,  
Bai Ling, W.Z. (2006). p53: Structure, Function and Therapeutic Applications, Journal of 
Cancer Molecules.2, 141-153.  
Ben-Porath, I., and Weinberg, R. (2004). When cells get stressed: an integrative view of 
cellular senescence. Journal of Clin. Investigation Vol 113 Issue 1,  
Bjørkøy, G., Lamark, T., Pankiv, S., Øvervatn, A., Brech, A., and Johansen, T. (2009). 
Monitoring autophagic degradation of p62/SQSTM1. Methods Enzymol 452, 181-97.  
Brady , L.W., Heilmann , H.P., Molls, M., and Nieder, C. advances in radiation oncology 
in Lung cancer.P.269-270.  
Breastcancer.org. U.S. Breast Cancer Statistics 2012,  
Bristol, M., Di, X., Beckman, M., Wilson, E., Henderson, S., Maiti, A., Fan, Z., and 
Gewirtz, D. (2012). Dual functions of autophagy in the response breast tumor cells to 
radiation: cytoprotective autophagy with radiation alone and cytotoxic autophagy in 
radiosenstization by Vitamin D3. Autophagy may; 1(8)5,  
 67 
Bullock, K., and Blackwell, K. (2008). Clinical efficacy of Taxane- Trastuzumab 
Combination Regimens for HER-2 Positive Metastatic Breast Cancer. The Oncologist 13 
No.5, 515-525.  
Bursch, W., Ellinger, A., Kienzl, H., Torok, L., Pandey, S., Sikorska, M., Walker, R., and 
Hermann, R.S. (1996). Active cell death induced by the anti-estrogens tamoxifen and ICI 
164 384 in human mammary carcinoma cells (MCF-7) in culture: the role of autophagy. 
Carcinogenesis 17, 1595-1607.  
Campisi, J. (2000). Cancer, aging and cellular senescence. In Vivo 14(1), 183-8.  
Campisi, J., and fagagna, F. (Sept 2008). Cellular senescence: when bad things happens 
to good cells. Nature Reviews, Molecular Cell Biology 8,  
Cancer Fact and Figures. (2012). 
http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/documents/docum
ent/acspc-031941.pdf.  
Cancer Factsheet N0297. (February 2012). 
http://www.who.int/mediacentre/factsheets/fs297/en/.  
Centers for Disease Control and Prevention. Cancer Prevention and Control, Cancer 
among men 2012,  
Chen , N., and Karantza- wadsworth , V. (2009). Role and Regulation of autophagy in 
cancer. Biochemica Et Biophysica Acta 1793(9), 1516- 1523.  
Chiou, S., Lee, H., Chi, C., Tu, P., LEE, Y., Chu, P., and Chen, L. (2012). Targeting 
Protective Autophagy Exacerbates UV-Triggered Apoptotic Cell Death. Int J Mol Sci 
13(1), 1209-24.  
Cookson, B., and Fink, S. (2005, April). Apoptosis, Pyrptosis and Necrosis: Mechnistic 
description of dead and dying cell in eukaryotic cells. Infect Immun 73(4), 1907–1916.  
Demasters, G., Di, X., Newsham, I., Shiu, R., and Gewirtz, D. (2006). Potentiation of 
radiation sensitivity of breast tumor cells by Vitamin D3 analogue, EB 1089, through 
promotion of autophagy and interference with proliferative recovery. Mol Cancer Ther 
Nov;5(11), 2786-97.  
DeSantis, C., Siegel, R., Bandi, P., and Jemal, A. (2011). Breast cancer statistics. A 
Cancer Journal for Clinicians 61, 408-418.  
Dooley, W. (1998). Surgery for Breast Cancer. Current Opinion in Oncology 10(6), 504-
12.  
 68 
Elmore, S. (2007). Apoptosis: A review of programmed cell death. Toxicol. Pathol 35(4), 
495-516.  
Eskelinen, E. (2011 aug). Dual role of autophagy in cancer. Curr Opin Pharmacol 11(4), 
294-300.  
Farber , E., Kanduc , D., Mittleman, A., Serpico, R., Sinigaglia, A., Sinha, A., Natale, C., 
Santacroce, R., Di Corcia, M., Lucchesse'A., et al. (2002). Cell death: apoptosis versus 
necrosis (review). International Journal of Oncology 21(1), 165-70.  
Foulkes, W.D., Smith, I.E., and Reis-Filho, J.S. (2010). Triple-Negative Breast cancer. 
The New England Journal of Medicine 363, 1938-1948.  
Fulda, S., and Debatin, K. (2006). Extrinsic versus Intrinsic apoptosis pathways in 
anticancer chemotherapy. Oncogene 25, 4798–4811.  
Gewirtz, D., Hilliker, M., and Wilson, E. (2009). promotion of autophagy as a 
mechanism of radiation sensitization of breast tumor cells. Radiother Oncol Sept 92(3), 
323-8.  
Hall, E., and Giaccia, A. Radiobiology for radiologist, 6th edition. In Lippincott Williams 
and Wilkins, Barrett K. ed.,  
Hanahan, D., and Weinberg, R. (Jan 2000). The Hallmarks of Cancer, Cell.100, 57-70.  
Hassan, M., Ansari, J., Spooner, D., and Hussain, S. (2010). Chemotherapy for Breast 
Cancer. Oncology Reports 24, 1121-1131.  
Hayflick, L., and Moorhead, P. The serial cultivation of human diploid cell strains. Exp 
Cell Res 1961, 585-621.  
Helleday, T., Lo, J., Van Gent , D., and Engelward, B. (2007). DNA double strand break 
repair: from mechanistic understanding to cancer treatment. DNA Repair (Amst) 6(7), 
923-35.  
Hengartner, M. (2000). The Biochemistry of Apoptosis. Nature 7, 770-776.  
Invasion and Metastases.(2002) In Holland-Frei Cancer Medicine, Bast, RC Jr, Kufe 
DW. and Pollock RE eds., Anonymous Learn about Cancer, Tumors that are not Cancers. 
Jiang, P.D., Zhao, Y.L., Deng, X.Q., Mao, Y.Q., Shi, W., Tang, Q.Q., Li, Z.G., Zheng, 
Y.Z., Yang, S.Y., and Wei, Y.Q. (2010). Antitumor and antimetastatic activities of 
chloroquine diphosphate in a murine model of breast cancer. Biomed. Pharmacother 609-
614.  
 69 
Jin, H., Pan, H., Wang, X., Jin, W., Chen, Y., Pan, Q., Li, D., Wang, K., Feng, L., Sun, J., 
and Han, W. (2011). Autophagy inhibition enhances daunorubicin –induced apoptosis in 
K562 cells. PLoS One 6(12), e28491.  
Kaufmann, S., Earnshaw, W., and Martins, L. (1999). Mammalian caspases: structure, 
activation, substrate and functions during apoptosis. Annual Review of Biochemostr 68, 
383-424.  
Kelekar, A., Lehmann, U., McDonnell, M., Wang, D., and Abedin, M. (2007). 
Autophagy delays apoptotic cell death in breast cancer cells following DNA damage. 
Cell Death Differ Mar;14(3), 500-10.  
Klionsky, D., and Geng, J. (2008). Quantitative regulation of vesicle formation in yeast 
non- specific autophagy. Autophagy Vol 4 Issue 7, 955-957.  
Klionsky, D., and Wen Wang, C. (2003 Mar-Apr). The molecular mechanism of 
autophagy. Molecular Medicine 9 (3-4), 65-76.  
Klionsky, D., Cuervo, A., and Saglen, P. (2007). Methods for monitoring autophagy from 
yeast to humans. Autophagy Autophagy 3:3, 181-206.  
Kondo, Y., Kanzawa, T., Sawaya, R., and Kondo, S. (2005). The role of autophagy in 
cancer development and response to therapy. Nature Reviews Cancer Sep;5(9), 726-34.  
Koukourakis, M., and Zois, C. (2009). radiation induced autophagy in normal and cancer 
cells: towards novel cytoprotection and radiosensitization policies? Autophagy May 5(4), 
442-50.  
Kroemer, G., Galluzi, L., Vitale, I., and Vacchelli, E. (2008). Cell Death signaling and 
Anticancer Therapy. Front Oncol May 8 (3), 207-220.  
Kroemer, G., and Jattela, M. (2005). Lysosome and autophagy in cell death control. 
Nature Reviews Cancer 5(11), 886-897.  
Lehmann, B., Bauer, J., Chen, X., Sanders, M., Chakravarthy, A., Shyr, Y., and 
Pietenpol, J. (2011). Identification of Triple- Negative breast cancer subtypes and 
preclinical models for selection of targeted therapy. J Clin Invest 121(7), 2750-2767.  
Liu, J., Zhang, X., Yang, X., Heckmann, BL.. (2012). The autophagic inhibitor 3-
Methyladenine (3-MA) potently stimulates PKA- dependent lipolysis in adipocytes, Br J 
Pharmacol. 2012, Jul 20. 
Liu, Z., Morgan, M., and Kim, Y. (2008). TNFα and Reactive Oxygen Species in necrotic 
cell death. Cell Research 18, 343-349.  
 70 
Lodish, H., Berk, A., and Zipursky, S. (2000). Tumor Cells and the Onset of Cancer. In 
Molecular Cell Biology, (New York: W.H. Freeman)  
Longo, R., Torino, F., and Gasparini, G. (2007). Targeted Therapy for Breast Cancer. 
Current Pharmaceutical Design 13 No. 5, 497-517(21).  
Mason, D., Jackson, T., and Lin, A. (2004, Dec 9). Molecular signature of oncogenic ras- 
induced senescence. Oncogene 23(57), 9238-46.  
Masuda, Y., and Kamiya, K. (2012). Molecular nature of radiation injury and DNA repair 
disorders associated with radiosensitivity. Int J Hematol 95(3), 239-45.  
Mayo Clinic. Breast cancer types: What your type means.  
Miller, K., Tjeertes, J., Coates, J., Legube, G., Polo, S., Britton, S., and Jackson, S. 
(2010). Human HDAC1 and HDAC2 function in the DNA- damage response to promote 
DNA non-homologous end joining. Nat. Struct Mol Biol 17(9), 1144-1151.  
Mizhushima, N. (Nov 15, 2007). Autophagy: Process and Function. Genes and 
Development 21(22), 2861-73.  
National cancer Institute. (2012). Drugs Approved for Breast 
Cancerhttp://www.cancer.gov/cancertopics/druginfo/breastcancer.2012,  
Neil, J., Kilbey, A., Terry, A., and Cameron, E. (2008). Oncogene induced senescence: 
an essential role for Runx. Cell Cycle August; 7(15), 2333-2340.  
Nielsen, A.,Anderson, K., Andersson M., Kamby C. (2010). Antiangiogenic therapy for 
breast cancer. Breast Cancer Res 12(5), 209.  
Osborne, C., Wilson, P., and Tripathy, D. (2004). Oncogenes and Tumor Suppressor 
Genes.9, 4361-377.  
Park, J., Song, J., Hyum, M.K., Hye Sook, han, H.,Sook, Seol, S.J., and Jang, J.C. p53-
Independent expression of wild-type p53-induced phosphatase 1 (Wip1) in 
methylmethane sulfonate-treated cancer cell lines and human tumors. The International 
Journal of Biochemistry and Cell Biology 44, 6-896-904.  
Porter, P.L. (2009). Global trends in breast cancer incidence and mortality. Salud Pública 
Méx 51, s141-s146.  
Potten, C., Booth, C., and Renehan, A. (2001). what is apoptosis and Why it is important. 
BMJ 322(7301), 1536–1538.  
Povirk, L. (2006). Biochemical mechanisms of chromosomal translocations resulting 
from DNA double strand breaks. DNA Repair (Amst). 5(9-10), 1199-212.  
 71 
Przyklenk, K., Mentzer, R.J., Gottlieb, R., Undyala, V., and Dong, Y. (2010). Autophagy: 
definition, molecular machinery, and potential role in myocardial ischemia-reperfusion 
injury. J Cardiovasc Pharmacol Ther Sep;15(3), 220-30.  
PubMed Health. (2012). Radiation Therapy.2012,  
Redmond, K., Wilson, T., Johnston, P., and Longley, D. (2008). Resistance mechanisms 
to Cancer chemotherapy. Frontiers in Bioscience: A Journal and Virtual Library 13, 
5138-54.  
Reis-Filho , J., Smith, I., and Foulkes , W. (2010). Triple negative breast cancer. The 
New England Journal of Medicine 363, 1938-48.  
Rodemann, H., Multhoff, G., Kehlbach, R., Toulany, M., Ohneseit, P., and Chachouay, 
H. (2011). Autophagy contributes to resistance to tumor cells to inonizing radiation. 
Radiother Oncol Jun;99(3), 287-92.  
Sawai, H., and Domae, H. (2011). Discrimination between primary necrosis and 
apoptosis by necrostatin-1 in Annexin V- positive/propidium iodide-negative cells. 
Biochem Biophys Res Commun Aug 5; 411(3), 569-73.  
Serrano, M., and Collado, M. (june 2006). The power and promise of oncogene induced 
senescence markers. Nature Reviews Cancer 6, ,472-476.  
Shen,HM and Codogno,P.(2011). Autophagic cell death Loch ness monster or 
endangered species?, Autophagy 7:5, 457-465. 
Shi, Y. (2002). Mechanisms of caspase Activation and Inhibition during Apoptosis 
Molecular Cell 9 Issue 3, 459-470.  
Smith, I., and Dowsett, M. (2003). Aromatase Inhibitors in Breast Cancer. The New 
England Journal of Medicine 348, 2431-2442.  
Soloman, V., and Lee, H. (2009). Chloroquine and its analogs: a new promise of an old 
drug for effective and safe cancer therapies. Eur J. Pharmacol 625, 220-233.  
Stewart, S., and Pazolli, E. (2008). Senescence: the good the bad and the dysfunctional. 
Current Opinions in Genetics and Developmen Volume 18 Issue 1, 42-47.  
Tanida, I., Ueno, T., and Kominame, E. (2008). LC3 and Autophagy, Autophagosome 
and Phagosome. Methods in Molecular Biology Vol 445, 77-88.  
Technical data sheet FITC Annexin V Apoptosis Detection Kit I. (2012).  
 72 
Toussaint, O., Campisi, J., Erusalimsky, J., and Debacq- Chainiaux, F. (2009). Protocols 
to detect senescence-associated beta galactosidase (SA-betagal) activity, a biomarker of 
senescent cells in culture and in vivo. Nat Protoc 4(12), 1798-806.  
Tsang, R., and Finn, R. (2012, Jan 3). BeyondTrastuzumab: novel therapeutic strategies 
in HER-2 Positive metastatic breast cancer. Br J Cancer 106(1), 6-13.  
Tschopp , J., Muller , C., and Peitsch, M. (1993). DNA fragmentation during apoptosis is 
caused by frequent single-strand cuts. Nucleic Acids Res Sep 11; 21(18), 4206-09.  
U.S. Food and Drug Administration. Http://www. Fda. 
gov/NewsEvents/Newsroom/PressAnnouncements/ucm280536. Htm 2012,  
Vandenabeele.P., Festjens. N., Berghe Vanden. T., Cornelis. S. (2007). RIP1, a kinase on 
the crossroads of a cell’s decision to live or die. Cell Death and Differentiation (2007) 14, 
400–410. doi:10.1038/sj.cdd.4402085.  
Vitale, I., Galluzzi, L., Catedo, M., and Kroemer, G. (2011). Mitotic Catastrophe: A 
mechanism to avoid genomic instability. Nature Reviews: Molecular Cell Biology 
June12; (6), 385-392.  
Vitale, I., Galluzzi, L., Vaccheli, E., and Kroemer, G. (2011). Cell Death Signaling & 
Anticancer Therapy. Frontiers in Oncology 1-5.  
Vousden, K.H. (2006). Outcomes of p53 activation- spoilt for choice 2006, Journal of 
Cell Science 119, 5015-5020.  
Wang , X. (2001). The expanding role of mitochondria in apoptosis. Genes & 
Development 15(22), 2922-33.  
Wax, A. Types of breast cancer: ER positive, HER2 positive, and triple negative.2012,  
White, E., and Wadsworth, M.R. (2007). Role of autophagy in cancer. Nat Rev Cancer 
December; 7(12), 961-967.  
White. E., Karp, C., Strohecker AM., Guo. Y., Mathew. R., (2010), Role of autophagy in 
suppression of inflammation and cancer; Curr Opin Cell Biol.2010 April;22(2)212-217. 
Wilson, E., Bristol, M., Xu, D., Maltese, W., Koterba, K., Beckman, M., and Gewirtz, D. 
(2011). A switch between cytoprotective and cytotoxic autophagy in the 
radiosensitization of breat tumor cells by Chloroquine and Vitamin D. Horm Cancer 
October 2(5), 272-285.  
Yanrong, S., Jarah, A., Meador, C.R., Geard, A., and Balajee, S. (2010). Analysis of 
ionizing radiation- induced DNA damage and repair in three-dimensional human skin 
model NCBI Aug 2012.  
 73 
Zhivotovsky, B., Olsson, M., and Vakifahmetoglu, H. (2008). Death through a tragedy: 
mitotic catastrophe. Cell Death and Differenciation 15, 1153-1162.  
Zisterer, D., Meegan, M., Nolan, D., O’Boyle, N., and Greene, L. (2012). The vascular 
targeting agent Combretastatin –A4 directly induces autophagy in adenocarcinoma-
derived colon cancer cells. Biochem Pharmacol Sept 1; 84(5), 612-24. 
 74 
VITA 
Shweta Moreshwar Chakrdaeo was born in Mumbai, India and is a citizen of India. She 
grew up in Kalyan, Maharshtra. She completed her undergraduate degree in Pharmacy 
from University of Mumbai in 2008. She joined Mega Lifesciences Pvt. Ltd as a brand 
executive and handled three neutraceutical brands in India. She joined Department of 
Pharmacology and Toxicology in January 2011 for master’s program. She has been 
working in Dr. Gewirtz’s laboratory as a master’s student. 
 
